Experienced pharmaceutical executive with over 18 years in clinical development, spanning startups to global pharmaceutical organizations. Proven expertise leading Phase 1–3 trials, regulatory submissions, and global clinical strategies across hematology, oncology, and rare diseases. Adept in cross-functional leadership, protocol development, safety monitoring, and pharmacovigilance. Recognized for driving innovation and accelerating trial execution through strategic trial design and data-driven insights.